265 related articles for article (PubMed ID: 32739148)
1. Safer opioid distribution in response to the COVID-19 pandemic.
Tyndall M
Int J Drug Policy; 2020 Sep; 83():102880. PubMed ID: 32739148
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings.
MacKinnon L; Socías ME; Bardwell G
J Subst Abuse Treat; 2020 Dec; 119():108153. PubMed ID: 33032862
[TBL] [Abstract][Full Text] [Related]
3. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
4. "If it wasn't for them, I don't think I would be here": experiences of the first year of a safer supply program during the dual public health emergencies of COVID-19 and the drug toxicity crisis.
Kolla G; Pauly B; Cameron F; Hobbs H; Ranger C; McCall J; Majalahti J; Toombs K; LeMaistre J; Selfridge M; Urbanoski K
Harm Reduct J; 2024 Jun; 21(1):111. PubMed ID: 38849866
[TBL] [Abstract][Full Text] [Related]
5. Tackling the overdose crisis: The role of safe supply.
Ivsins A; Boyd J; Beletsky L; McNeil R
Int J Drug Policy; 2020 Jun; 80():102769. PubMed ID: 32446183
[TBL] [Abstract][Full Text] [Related]
6. Stimulant safe supply: a potential opportunity to respond to the overdose epidemic.
Fleming T; Barker A; Ivsins A; Vakharia S; McNeil R
Harm Reduct J; 2020 Jan; 17(1):6. PubMed ID: 31924209
[TBL] [Abstract][Full Text] [Related]
7. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States.
Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE
Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493
[TBL] [Abstract][Full Text] [Related]
8. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
[TBL] [Abstract][Full Text] [Related]
9. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
10. The drug war must end: The right to life, liberty and security of the person during the COVID-19 pandemic for people who use drugs.
; ; ; Maynard R; Jozaghi E
Harm Reduct J; 2021 Feb; 18(1):21. PubMed ID: 33596901
[TBL] [Abstract][Full Text] [Related]
11. A Dynamic Model of Opioid Overdose Deaths in Canada during the Co-Occurring Opioid Overdose Crisis and COVID-19 Pandemic.
Zahan R; Osgood ND; Plouffe R; Orpana H
Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673354
[TBL] [Abstract][Full Text] [Related]
12. Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.
Giang K; Charlesworth R; Thulien M; Mulholland A; Barker B; Brar R; Pauly B; Fast D
Int J Drug Policy; 2023 May; 115():104023. PubMed ID: 37059025
[TBL] [Abstract][Full Text] [Related]
13. "It wasn't here, and now it is. It's everywhere": fentanyl's rising presence in Oregon's drug supply.
Shin SS; LaForge K; Stack E; Pope J; Leichtling G; Larsen JE; Leahy JM; Seaman A; Hoover D; Chisholm L; Blazes C; Baker R; Byers M; Branson K; Korthuis PT
Harm Reduct J; 2022 Jul; 19(1):76. PubMed ID: 35818072
[TBL] [Abstract][Full Text] [Related]
14. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
Mistler CB; Chandra DK; Copenhaver MM; Wickersham JA; Shrestha R
J Community Health; 2021 Apr; 46(2):349-357. PubMed ID: 32997253
[TBL] [Abstract][Full Text] [Related]
15. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
16. The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
Yeo Y; Johnson R; Heng C
Mil Med; 2022 Aug; 187(9-10):244-247. PubMed ID: 34908134
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl and the Evolving Opioid Epidemic: What Strategies Should Policy Makers Consider?
Barry CL
Psychiatr Serv; 2018 Jan; 69(1):100-103. PubMed ID: 28967324
[TBL] [Abstract][Full Text] [Related]
18. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL
Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642
[No Abstract] [Full Text] [Related]
19. The Opioid Crisis: Prevalence and Markets of Opioids.
Gardner EA; McGrath SA; Dowling D; Bai D
Forensic Sci Rev; 2022 Jan; 34(1):43-70. PubMed ID: 35105535
[TBL] [Abstract][Full Text] [Related]
20. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
